The Bespoke Rare Disease Specialty Pharmacy
Programs & Services
High Touch Patient, Caregiver & Provider Support
Curant Rare is empowered by Medication Care Management®, our signature high-touch approach that goes beyond traditional therapy management:
-
We provide continuous, personalized support for patients, caregivers, and providers to ensure lasting adherence and improved outcomes throughout the rare disease journey.
-
By taking a longitudinal and relational approach, we help patients maintain consistency in their treatment while giving providers the insights they need to make informed, proactive care decisions.
Our implementation and commercial teams bring centuries of combined industry and data expertise to deliver the best possible experience
Our dedicated pharmacists and robust clinical team ensure optimal patient access by focusing on and eliminating barriers to therapy
Every patient and caregiver has a dedicated team providing comprehensive care and personalized support to manage the rare journey
Compassionate Use Expanded Access Programs (EAPs)
Curant Rare delivers full-service support for Expanded Access Programs, managing logistics, regulatory requirements, and communication so innovative therapies reach patients safely and efficiently.
- Our high-touch, compassionate model supports patients and providers at every step; streamlining processes, simplifying documentation, and ensuring clear education and follow-up.
- By connecting patients, providers, and manufacturers, we accelerate access to life-changing therapies and create meaningful impact for those who need it most.
Eliminate the inefficiencies for your Expanded Access Program and your commercial distribution strategy
Through the EAP, we model your commercial program to ensure a seamless launch at approval
As your early access and commercial partner, we are fully invested in your product’s long-term success
Realtime Commercial Data & Real World Evidence
Curant Rare leverages Real-Time Insights (RTI) and Real-World Evidence (RWE):
- By collecting Patient Reported Outcomes (PROs) and analyzing treatment trends, we provide actionable insights that demonstrate both patient impact and program effectiveness.
-
We provide pharma partners with daily patient status reporting, ensuring complete visibility into each patient’s journey at all times. Our streamlined, reliable data delivery removes the administrative burden while supporting the detailed needs of rare disease programs.
-
Our approach ensures that every intervention, every interaction, and every care plan is accessible, actionable, and accountable to drive better outcomes.
We help our partners show the measurable impact of their therapies to payers, regulators, and stakeholders, strengthening market access and reimbursement strategies
Providing actionable insights directly from patients’ experiences, enabling more precise, evidence-based decisions from pre-PDUFA to post-marketing launch
Insights that reveal what matters to patients, tailored support programs, improved adherence, as well as providing actionable and meaningful results
Projects
Curant Rare Announces Pharmacy Partnership with Corcept Therapeutics
Curant Rare Announces Exclusive Pharmacy Partnership for IWILFIN™